These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 34706754)

  • 1. Can harmful lifestyle, obesity and weight changes increase the risk of breast cancer in BRCA 1 and BRCA 2 mutation carriers? A Mini review.
    Daniele A; Divella R; Pilato B; Tommasi S; Pasanisi P; Patruno M; Digennaro M; Minoia C; Dellino M; Pisconti S; Casamassima P; Savino E; Paradiso AV
    Hered Cancer Clin Pract; 2021 Oct; 19(1):45. PubMed ID: 34706754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smoking and physical inactivity increase cancer prevalence in BRCA-1 and BRCA-2 mutation carriers: results from a retrospective observational analysis.
    Grill S; Yahiaoui-Doktor M; Dukatz R; Lammert J; Ullrich M; Engel C; Pfeifer K; Basrai M; Siniatchkin M; Schmidt T; Weisser B; Rhiem K; Ditsch N; Schmutzler R; Bischoff SC; Halle M; Kiechle M
    Arch Gynecol Obstet; 2017 Dec; 296(6):1135-1144. PubMed ID: 28975393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.
    Franceschini G; Di Leone A; Terribile D; Sanchez MA; Masetti R
    Ann Ital Chir; 2019; 90():1-2. PubMed ID: 30872561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lifestyle Risk Factors for Breast Cancer in BRCA1/2-Mutation Carriers Around Childbearing Age.
    van Erkelens A; Derks L; Sie AS; Egbers L; Woldringh G; Prins JB; Manders P; Hoogerbrugge N
    J Genet Couns; 2017 Aug; 26(4):785-791. PubMed ID: 27966054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline breast cancer susceptibility gene mutations and breast cancer outcomes.
    Wang YA; Jian JW; Hung CF; Peng HP; Yang CF; Cheng HS; Yang AS
    BMC Cancer; 2018 Mar; 18(1):315. PubMed ID: 29566657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of lifestyle intervention in BRCA1/2 mutation carriers on nutrition, BMI, and physical fitness (LIBRE study): study protocol for a randomized controlled trial.
    Kiechle M; Engel C; Berling A; Hebestreit K; Bischoff SC; Dukatz R; Siniatchkin M; Pfeifer K; Grill S; Yahiaoui-Doktor M; Kirsch E; Niederberger U; Enders U; Löffler M; Meindl A; Rhiem K; Schmutzler R; Erickson N; Halle M
    Trials; 2016 Jul; 17():368. PubMed ID: 27473440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diet, lifestyle and BRCA-related breast cancer risk among French-Canadians.
    Nkondjock A; Robidoux A; Paredes Y; Narod SA; Ghadirian P
    Breast Cancer Res Treat; 2006 Aug; 98(3):285-94. PubMed ID: 16541324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weight History, Smoking, Physical Activity and Breast Cancer Risk among French-Canadian Women Non-Carriers of More Frequent BRCA1/2 Mutations.
    Bissonauth V; Shatenstein B; Fafard E; Maugard C; Robidoux A; Narod S; Ghadirian P
    J Cancer Epidemiol; 2009; 2009():748367. PubMed ID: 20445803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone replacement therapy in BRCA mutation carriers and risk of ovarian, endometrial, and breast cancer: a systematic review.
    Huber D; Seitz S; Kast K; Emons G; Ortmann O
    J Cancer Res Clin Oncol; 2021 Jul; 147(7):2035-2045. PubMed ID: 33885953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRCA1/BRCA2 mutations in Japanese women with ductal carcinoma in situ.
    Liu Y; Ide Y; Inuzuka M; Tazawa S; Kanada Y; Matsunaga Y; Kuwayama T; Sawada T; Akashi-Tanaka S; Nakamura S
    Mol Genet Genomic Med; 2019 Mar; 7(3):e493. PubMed ID: 30652428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of body size and physical activity on the risk of breast cancer in BRCA mutation carriers.
    Pettapiece-Phillips R; Narod SA; Kotsopoulos J
    Cancer Causes Control; 2015 Mar; 26(3):333-44. PubMed ID: 25579073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical management of breast cancer in BRCA-mutation carriers: a systematic review and meta-analysis.
    Valachis A; Nearchou AD; Lind P
    Breast Cancer Res Treat; 2014 Apr; 144(3):443-55. PubMed ID: 24567198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic irradiation to the contralateral breast for BRCA mutation carriers with early-stage breast cancer.
    Evron E; Ben-David AM; Goldberg H; Fried G; Kaufman B; Catane R; Pfeffer MR; Geffen DB; Chernobelsky P; Karni T; Abdah-Bortnyak R; Rosengarten O; Matceyevsky D; Inbar M; Kuten A; Corn BW
    Ann Oncol; 2019 Mar; 30(3):412-417. PubMed ID: 30475942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic Profiling Comparison of Germline
    Huang X; Shao D; Wu H; Zhu C; Guo D; Zhou Y; Chen C; Lin Y; Lu T; Zhao B; Wang C; Sun Q
    Front Oncol; 2020; 10():583314. PubMed ID: 33194720
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of lifestyle factors on preneoplastic changes in prophylactic oophorectomies of BRCA mutation carriers.
    Primas H; Kroiss R; Kalteis K; Rappaport C; Muhr D; Primas C; Kubista E; Horvat R; Oefner P; Singer C; Wagner And The Austrian Hereditary Breast And Ovarian Cancer Group T
    Eur J Cancer Prev; 2012 Mar; 21(2):199-204. PubMed ID: 22252303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective evaluation of body size and breast cancer risk among BRCA1 and BRCA2 mutation carriers.
    Kim SJ; Huzarski T; Gronwald J; Singer CF; Møller P; Lynch HT; Armel S; Karlan BY; Foulkes WD; Neuhausen SL; Senter L; Eisen A; Eng C; Panchal S; Pal T; Olopade O; Zakalik D; Lubinski J; Narod SA; Kotsopoulos J;
    Int J Epidemiol; 2018 Jun; 47(3):987-997. PubMed ID: 29547931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of breast cancer after a diagnosis of ovarian cancer in BRCA mutation carriers: Is preventive mastectomy warranted?
    McGee J; Giannakeas V; Karlan B; Lubinski J; Gronwald J; Rosen B; McLaughlin J; Risch H; Sun P; Foulkes WD; Neuhausen SL; Kotsopoulos J; Narod SA;
    Gynecol Oncol; 2017 May; 145(2):346-351. PubMed ID: 28314588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current guidelines for BRCA testing of breast cancer patients are insufficient to detect all mutation carriers.
    Grindedal EM; Heramb C; Karsrud I; Ariansen SL; Mæhle L; Undlien DE; Norum J; Schlichting E
    BMC Cancer; 2017 Jun; 17(1):438. PubMed ID: 28637432
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.